Topics

TAVR Survival Surpasses SAVR in Low-Risk Patients: Meta-analysis

10:31 EDT 17 Sep 2019 | Medscape

The results suggest TAVR should be the preferred option in low-risk patients, but the author and observers caution against widespread application beyond the inclusion criteria of the individual trials.
Medscape Medical News

Original Article: TAVR Survival Surpasses SAVR in Low-Risk Patients: Meta-analysis

NEXT ARTICLE

More From BioPortfolio on "TAVR Survival Surpasses SAVR in Low-Risk Patients: Meta-analysis"

Quick Search